Keywords
neuropatía periférica
Proteína Mielina Cero
mutación
Costa Rica.
Charcot-Marie-Tooth
peripheral neuropathy
Myelin protein zero
mutation
Costa Rica
How to Cite
Abstract
La mutación p.thr124Met en la proteína mielina cero (MPZ) causa la enfermedad de Charcot-Marie-Tooth tipo 2J, una neuropatía periférica con síntomas adicionales como alteraciones pupilares y sordera. Se ha observado en varias familias alrededor del mundo, originarias de Alemania, Bélgica, Japón, Italia y Norteamérica, entre otras. Aquí reportamos a pacientes centroamericanos provenientes de Costa Rica que acarrean esta mutación. Se realizaron análisis clínico, electrofisiológico y molecular de pacientes y controles, incluyendo secuenciación del gen y de marcadores ligados a éste. Estos pacientes comparten casi por completo el haplotipo con dos pacientes belgas no emparentados. Como resultado del análisis de los haplotipos, basado en diez marcadores (siete SNPs, dos microsatélites y un elemento poli-A intrónico), se sugiere que se ha dado un efecto fundador en la migración de este alelo.References
Baloh, R. H., Jen, J. C., Kim, C., & Baloh, R.W. (2004). Chronic cough due to Thr124Met mutation in the peripheral myelin protein zero (MPZ gene). Neurology, 62(10), 1905-1906.
Berghoff, C., Berghoff, M., Leal, A., Morera, B., Barrantes, R., Reis, A., Neundoerfer, B., Rautenstrauss, B., Del Valle, G., & Heuss, D. (2004). Clinical and electrophysiological characteristics of autosomal recessive axonal Charcot-Marie-Tooth disease (CMT2B2) that maps to chromosome 19q13.3. Neuromuscular Disorders, 14, 301-306.
Carenini, S., Maurer, M., Werner, A., Blazyca, H., Toyka, K. V., Schmid, C. D., Raivich, G., & Martini, R. (2001). The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. Journal of Cellular Biology, 152, 301-308.
Chapon, F., Latour, P., Diraison, P., Schaeffer, S., & Vandenberghe, A. (1999). Axonal phenotype of Charcot-Marie Tooth disease associated with a mutation in the myelin protein zero gene. Journal of Neurology, Neurosurgery and Psychiatry, 66, 779-782.
De Jonghe, P., Timmerman, V., Ceuterick, C., Nelis, E., De Vriendt, E., Löfgren, A., Vercruyssen, A., Verellen, C., Van Maldergem, L., Martin, J., & Van Broeckhoven, C. (1999). The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain, 122, 281-290.
Dyck, P., Chance, P., Lebo, R., & Carney, J. (1993). Hereditary motor and sensory neuropathies. In P. Dyck, P. Thomas, J. Griffin, P. Low, & J. Poduslo (Eds.), Peripheral neuropathies (pp. 1094-1136). Philadelphia: Saunders.
Frei, R., Motzing, S., Kinkelin, I., Schachner, M., Koltzenburg, M., & Martini, R. (1999). Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. Journal of Neuroscience, 19, 6058-6067.
Gabreëls-Festen, A. A., Hoogendijk, J. E., Meijerink, P. H., Gabreëls, F. J., Bolhuis, P. A, van Beersum, S., Kulkens, T., Nelis, E., Jennekens, F. G., de Visser, M., van Engelen, B. G., Van Broeckhoven, C., & Mariman, E. C. (1996). Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology, 47, 761-765.
Gallardo, E., García, A., Ramón, C., Maraví, E., Infante, J., Gastón, I., Alonso, A., Combarros, O., Jonghe, P. D., & Berciano, J. (2009). Charcot-Marie–Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family. Journal of Neurology, 256, 2061-2071.
Giese, K. P., Martini, R., Lemke, G., Soriano, P., & Schachner, M. (1992). Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell, 71, 565-576.
Hanemann, C. O., Gabreëls-Festen, A. A., & De Jonghe, P. (2001). Axon damage in CMT due to mutation in myelin protein P0. Neuromuscular Disorders, 11(8), 753-756.
Hayasaka, K., Himoro, M., Sato, W., Takada, G., Uyemura, K., Shimizu, N., Bird, T. D., Conneally, P. M., & Chance, P. F. (1993a). Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P(0) gene. Nature Genet, 5, 31-34.
Hayasaka, K., Himoro, M., Sawaishi, Y., Nanao, K., Takahashi, T., Takada, G., Nicholson, G. A., Ouvrier, R. A., & Tachi, N. (1993b). De novo mutation of the myelin Po gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nature Genetics, 5, 266-268.
Hayasaka, K., Himoro, M., Wang, Y., Takata, M., Minoshima, S., Shimizu, N., Miura, M., Uyemura, K., & Takada, G. (1993c). Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics, 17, 755-758.
Kurihara, S., Adachi, Y., Wada, K., Adachi, A., Ohama, E., & Nakashima, K. (2003). Axonal and demyelinating forms of the MPZ Thr124Met mutation. Acta Neurologica Scandinavica, 108, 157-160.
Kurihara, S., Adachi, Y., Wada, K., Awaki, E., Harada, H., & Nakashima, K. (2002). An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan. Neuroepidemiology, 21(5), 246-250.
Leal, A., Berghoff, C., Berghoff, M., Del Valle, G., Contreras, C., Montoya, O., Hernández, E., Barrantes, R., Schoetzer-Schrehardt, U., Neundoerfer, B., Reis, A., Rautenstrauss, B., & Heuss, D. (2003). Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family. Neurogenetics, 4, 191-197.
Lupski, J. (1998). Molecular genetics of peripheral neuropathies. In J. Martin (Ed.), Scientific American Molecular Neurology (pp. 239-256). New York: Scientific American Library.
Marrosu, M. G., Vaccargiu, S., Marrosu, G., Vannelli, A., Cianchetti, C., & Muntoni, F. (1998). Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology, 50, 1397-1401.
Martini, R., Zielasek, J., Toyka, K. V., Giese, K. P., & Schachner, M. (1995). Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genetics, 11, 281-286.
Morera, B., Barrantes, R., & Marin-Rojas, R. (2003). Gene admixture in the Costa Rican population. Annals of Human Genetics, 67, 71-80.
Nelis, E., Timmerman, V., De Jonghe, P., Vandenberghe, A., Pham-Dinh, D., Dautigny, A., Martin, J. J., & Van Broeckhoven, C. (1994). Rapid screening of myelin genes in CMT1 patients by SSCP analysis: identification of new mutations and polymorphisms in the P0 gene. Human Genetics, 94(6), 653-657.
Misu, K., Yoshihara, T., Shikama, Y., Awaki, E., Yamamoto, M., Hattori, N., Hirayama, M., Takegami, T., Nakashima, K., & Sobue, G. (2000). An axonal form of Charcot–Marie–Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). Journal of Neurology, Neurosurgery and Psychiatry, 69, 806-811.
Nachman, M. W. & Crowell, S. L. (2000). Estimate of the mutation rate per nucleotide in humans. Genetics, 156, 297-304.
Numakura, C., Lin, C., Ikegami, T., Guldberg, P., & Hayasaka, K. (2002). Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Human Mutation, 20(5), 392-398.
Rautenstrauß, B., Nelis, E., Grehl, H., Pfeiffer, R. A., & Van Broeckhoven, C. (1994) Identification of a de novo insertional mutation in P0 in a patient with Déjerine-Sottas phenotype. Human Molecular Genetics, 3(9), 1701-1702.
Schiavon, F., Rampazzo, A., Merlini, L., Angelini, C., & Mostacciuolo, M. L. (1998). Mutations of the same sequence of the myelin P0 gene causing two different phenotypes. Human Mutation, 11, S217-S219.
Schröder, J. M. & Himmelmann, F. (1992). Fine structural evaluation of altered Schmidt-Lanterman incisures in human sural nerve biopsies. Acta Neuropatholica (Berlin), 83, 120-133.
Seeman, P., Mazanec, R., Huehne, K., Suslikova, P., Keller, O., & Rautenstrauss, B. (2004). Hearing loss as the first feature of leta-onset axonal CMT disease due to a novel P0 mutation. Neurology, 63, 733-735.
Senderek, J., Hermanns, B., Lehmann, U., Bergmann, C., Marx, G., Kabus, C., Timmerman, V., Stoltenburg-Didinger, G., & Schroder, J. M. (2000). Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathology, 10, 235-248.
Starr, A., Michalewski, H. J., Zeng, F. G., Fujikawa-Brooks, S., Linthicum, F., Kim, C. S., Winnier, D., & Keats, B. (2003). Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145Ser). Brain, 126, 1-16.
Stojkovic, T., de Seze, J., Dubourg, O., Arne-Bes, M. C., Tardieu, S., Hache, J. C., & Vermersch, P. (2003). Autonomic and respiratory dysfunction in Charcot–Marie–Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clinical Neurophysiology, 114, 1609-1614.
Warner, L. E., Hilz, M. J., Appel, H., Killian, J. M., Kolodny, E. H., Carpenter, S., Watters, G. V., Wheeler, C., Witt, D., Bodell, A., Nelis, E., Van Broeckhoven, C., & Lupski, J. R. (1996). Clinical phenotypes of different mpz (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron, 17, 451-460.
Yoshihara, T., Yamamoto, M., Doyu, M., Mis, K. I., Hattori, N., Hasegawa, Y., Mokuno, K., Mitsuma, T., & Sobue, G. (2000). Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease. Human Mutation, 16, 177-178.
Young, P., Grote, K., Kuhlenbaumer, G., Debus, O., Kurlemann, H., Halfter, H., Funke, H., Ringelstein, E. B., & Stogbauer, F. (2001). Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity. Journal of Neurology, 248, 410-415.
Comments
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2014 Revista de Biología Tropical